179
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Anemia Severely Reduces Health-Related Quality of Life in COPD Patients Receiving Long-Term Home Non-Invasive Ventilation

, ORCID Icon, , ORCID Icon, , , ORCID Icon & ORCID Icon show all
Pages 2963-2971 | Published online: 28 Oct 2021

References

  • Mathers CD, Loncar D, Samet J. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442. doi:10.1371/journal.pmed.0030442
  • Mannino DM. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest. 2002;121(5):121S–126S.
  • Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5):1418–1422.
  • Sundh J, Ställberg B, Lisspers K, Montgomery SM, Janson C. Co-morbidity, body mass index and quality of life in COPD using the clinical COPD questionnaire. COPD. 2011;8(3):173–181.
  • Ketelaars C, Schlösser M, Mostert R, Abu-Saad HH, Halfens R, Wouters E. Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. Thorax. 1996;51(1):39–43.
  • Lee H, Jhun BW, Cho J, et al. Different impacts of respiratory symptoms and comorbidities on COPD-specific health-related quality of life by COPD severity. Int J Chron Obstruct Pulmon Dis. 2017;12:3301.
  • Esteban C, Arostegui I, Aramburu A, et al. Predictive factors over time of health-related quality of life in COPD patients. Respir Res. 2020;21:1–11.
  • Krishnan G, Grant BJ, Muti PC, et al. Association between anemia and quality of life in a population sample of individuals with chronic obstructive pulmonary disease. BMC Pulm Med. 2006;6(1):1–9.
  • Similowski T, Agusti A, MacNee W, Schönhofer B. The potential impact of anaemia of chronic disease in COPD. Euro Respir J. 2006;27(2):390–396.
  • Cranston JM, Crockett A, Moss J, Alpers JH. Domiciliary oxygen for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2005;4:CD001744.
  • Wilson ME, Dobler CC, Morrow AS, et al. Association of home noninvasive positive pressure ventilation with clinical outcomes in chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA. 2020;323(5):455–465.
  • Kohnlein T, Windisch W, Kohler D, et al. Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial. Lancet Respir Med. 2014;2(9):698–705.
  • Murphy PB, Rehal S, Arbane G, et al. Effect of home noninvasive ventilation with oxygen therapy vs oxygen therapy alone on hospital readmission or death after an acute COPD exacerbation: a randomized clinical trial. JAMA. 2017;317(21):2177–2186.
  • Testa MA, Simonson DC. Assessment of quality-of-life outcomes. N Engl J Med. 1996;334(13):835–840.
  • Windisch W, Freidel K, Schucher B, et al. The Severe Respiratory Insufficiency (SRI) Questionnaire A specific measure of health-related quality of life in patients receiving home mechanical ventilation. J Clin Epidemiol. 2003;56(8):752–759.
  • Windisch W. Impact of home mechanical ventilation on health-related quality of life. Eur Respir J. 2008;32(5):1328–1336.
  • Walterspacher S, July J, Kohlhäufl M, Rzehak P, Windisch W. The Severe Respiratory Insufficiency Questionnaire for subjects with COPD with long-term Oxygen therapy. Respir Care. 2016;61(9):1186–1191.
  • Köhnlein T, Windisch W, Köhler D, et al. Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial. Lancet Respir Med. 2014;2(9):698–705.
  • Association WM. Declaration of Helsinki-Ethical principles for medical research involving human subjects official version 2013. JAMA. 2013;310:20.
  • von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–1457.
  • Schwarz SB, Mathes T, Majorski DS, et al. Living conditions and autonomy levels in COPD patients receiving non-invasive ventilation: impact on health related quality of life. BMC pulmonary medicine. 2021;21(1):1–8.
  • GOLD. Global Initiative for Chronic Obstructive Lung Disease Report. Fontana, WI; 2021. Available from: www.goldcopd.org. Accessed October 16, 2021.
  • Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–682.
  • Windisch W, Geiseler J, Simon K, Walterspacher S, Dreher M; on behalf of the Guideline C. German national guideline for treating chronic respiratory failure with invasive and non-invasive ventilation: revised edition 2017 - Part 1. Respiration. 2018;96(1):66–97.
  • Windisch W, Geiseler J, Simon K, Walterspacher S, Dreher M; on behalf of the Guideline C. German national guideline for treating chronic respiratory failure with invasive and non-invasive ventilation - Revised Edition 2017: Part 2. Respiration. 2018;96(2):171–203.
  • Windisch W. Quality of life in home mechanical ventilation study group. Impact of home mechanical ventilation on health-related quality of life. Eur Respir J. 2008 32(5):1328–36. 
  • WHO. Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity. Geneva: Vitamin and Mineral Nutrition Information System. (WHO/NMH/NHD/MNM/11.1); 2011. Available from: http://www.who.int/vmnis/indicators/haemoglobin.pdf. Accessed May 23, 2021.
  • Cote C, Zilberberg M, Mody SH, Celli B. The prevalence of polycythemia in a chronic obstructive pulmonary disease (COPD) cohort. Chest. 2005;128(4):264S.
  • Raveling T, Kort J, Bladder G, Windisch W, Wijkstra PJ, Duiverman ML. The minimal clinically important difference of the Severe Respiratory Insufficiency questionnaire in severe COPD. Eur Respir J. 2020;56:6.
  • Xiong W, Xu M, Pudasaini B, Guo X, Liu J. The influence of anemia on one-year exacerbation rate of patients with COPD-PH. BMC Pulm Med. 2018;18(1):1–8.
  • Yohannes AM, Ershler WB. Anemia in COPD: a systematic review of the prevalence, quality of life, and mortality. Respir Care. 2011;56(5):644–652.
  • Ferrari M, Manea L, Anton K, et al. Anemia and hemoglobin serum levels are associated with exercise capacity and quality of life in chronic obstructive pulmonary disease. BMC Pulm Med. 2015;15(1):1–8.
  • Miravitlles M, Ferrer M, Pont A, et al. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax. 2004;59(5):387–395.
  • Niewoehner DE. The impact of severe exacerbations on quality of life and the clinical course of chronic obstructive pulmonary disease. Am J Med. 2006;119(10):38–45.
  • Esteban C, Quintana JM, Moraza J, et al. Impact of hospitalisations for exacerbations of COPD on health-related quality of life. Respir Med. 2009;103(8):1201–1208.
  • Quirt I, Robeson C, Lau C, et al. Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy. J Clin Oncol. 2001;19(21):4126–4134.
  • Jones M, Schenkel B, Just J, Fallowfield L. Epoetin alfa improves quality of life in patients with cancer: results of a metaanalysis. Cancer. 2004;101(8):1720–1732.
  • Ergan B, Oczkowski S, Rochwerg B, et al. European Respiratory Society guidelines on long-term home non-invasive ventilation for management of COPD. Eur Respir J. 2019;54:3.